These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7934594

  • 1. Immune-mediated inner ear disease and parvovirus B19.
    Cotter CS, Singleton GT, Corman LC.
    Laryngoscope; 1994 Oct; 104(10):1235-9. PubMed ID: 7934594
    [Abstract] [Full Text] [Related]

  • 2. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS, Meyerhoff WE, Cohen SB.
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [Abstract] [Full Text] [Related]

  • 3. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T.
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [Abstract] [Full Text] [Related]

  • 4. Active or recent parvovirus B19 infection in children with Kawasaki disease.
    Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, Musiani M.
    Lancet; 1994 May 21; 343(8908):1260-1. PubMed ID: 7910278
    [Abstract] [Full Text] [Related]

  • 5. Adult human parvovirus-B19 infection presenting with hearing difficulty and dizziness.
    Nara M, Shirata Y, Kikuchi T, Hongo M.
    Tohoku J Exp Med; 2011 May 21; 224(1):57-9. PubMed ID: 21551982
    [Abstract] [Full Text] [Related]

  • 6. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N, Ağaçfidan A, Ağirbaşli H, Işik DM, Bozkaya E, Gedikoğlu G, Badur S.
    Mikrobiyol Bul; 2003 Oct 21; 37(4):277-83. PubMed ID: 14748265
    [Abstract] [Full Text] [Related]

  • 7. [Systemic manifestations of Parvovirus B19 infections].
    Sève P, Ferry T, Charhon A, Calvet A, Broussolle C.
    Rev Med Interne; 2004 Oct 21; 25(10):740-51. PubMed ID: 15471600
    [Abstract] [Full Text] [Related]

  • 8. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M, Juchler A, Flaviano A, Kaeppeli F.
    Gynecol Obstet Invest; 2007 Oct 21; 63(1):53-4. PubMed ID: 16940737
    [Abstract] [Full Text] [Related]

  • 9. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
    Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, MacGregor RR, Friedman HM.
    Clin Infect Dis; 1995 Jan 21; 20(1):170-3. PubMed ID: 7727646
    [Abstract] [Full Text] [Related]

  • 10. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period.
    Rao SP, Miller ST, Cohen BJ.
    Am J Dis Child; 1992 Nov 21; 146(11):1328-30. PubMed ID: 1415073
    [Abstract] [Full Text] [Related]

  • 11. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA, Leslie EE, Smith S, O'Neill HJ, Hart H, Cohen BJ, Inglis JM.
    J Clin Pathol; 1993 Sep 21; 46(9):840-5. PubMed ID: 8227436
    [Abstract] [Full Text] [Related]

  • 12. Association between human parvovirus B19 infection and arthritis.
    Cassinotti P, Bas S, Siegl G, Vischer TL.
    Ann Rheum Dis; 1995 Jun 21; 54(6):498-500. PubMed ID: 7632094
    [Abstract] [Full Text] [Related]

  • 13. Human parvovirus B19: immunity of Greek females and prenatal investigation of hydrops fetalis.
    Kyriazopoulou V, Simitsopoulou M, Bondis J, Diza E, Athanasiadis A, Frantzidou F, Souliou E.
    Eur J Obstet Gynecol Reprod Biol; 1997 Aug 21; 74(2):157-60. PubMed ID: 9306109
    [Abstract] [Full Text] [Related]

  • 14. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?
    Finkel TH, Török TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR.
    Lancet; 1994 May 21; 343(8908):1255-8. PubMed ID: 7910276
    [Abstract] [Full Text] [Related]

  • 15. Erythematous exanthem associated with primary infection by human parvovirus B19.
    Veraldi S, Rizzitelli G.
    Int J Dermatol; 1995 Feb 21; 34(2):119. PubMed ID: 7737770
    [No Abstract] [Full Text] [Related]

  • 16. Parvovirus B19-induced chronic arthropathy in a child.
    Lopreiato JO, Katona IM.
    Clin Pediatr (Phila); 1993 May 21; 32(5):305-7. PubMed ID: 8324977
    [No Abstract] [Full Text] [Related]

  • 17. Immunosuppressive therapy for autoimmune inner ear disease.
    Buniel MC, Geelan-Hansen K, Weber PC, Tuohy VK.
    Immunotherapy; 2009 May 21; 1(3):425-34. PubMed ID: 19885385
    [Abstract] [Full Text] [Related]

  • 18. Antibodies anti-parvovirus B19 in chronic hepatitis C virus infection.
    Lavorino C, Mannella E, Salvatori L, Delle Monache M, Santolamazza M, Gerardi R, Berardo C, Bacosi M, Ricci GL.
    Am J Gastroenterol; 1995 Apr 21; 90(4):676-7. PubMed ID: 7717346
    [No Abstract] [Full Text] [Related]

  • 19. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
    Corcoran A, Doyle S, Waldron D, Nicholson A, Mahon BP.
    J Virol; 2000 Nov 21; 74(21):9903-10. PubMed ID: 11024117
    [Abstract] [Full Text] [Related]

  • 20. Parvovirus B19-related lymphadenopathy.
    Tsuda H, Maeda Y, Nakagawa K.
    Br J Haematol; 1993 Nov 21; 85(3):631-2. PubMed ID: 8136290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.